184 related articles for article (PubMed ID: 17874221)
1. Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease.
Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai YH; Tsai CH; Chen CP; Tsai FJ
Pediatr Cardiol; 2008 Mar; 29(2):292-6. PubMed ID: 17874221
[TBL] [Abstract][Full Text] [Related]
2. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children.
Huang FY; Chang TY; Chen MR; Lee HC; Chi H; Chiu NC; Hsu CH; Lin SP; Kao HA; Chen WF; Chan HW; Liu HF; Chu CC; Lin M; Lee YJ
J Clin Immunol; 2008 Jul; 28(4):322-8. PubMed ID: 18297377
[TBL] [Abstract][Full Text] [Related]
4. Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease.
Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai YH; Tsai CH; Chen CP; Tsai FJ
J Korean Med Sci; 2009 Jun; 24(3):438-42. PubMed ID: 19543506
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children.
Weng KP; Hsieh KS; Huang SH; Wu HW; Chien JH; Lin CC; Tang CW; Ou SF; Huang SJ; Ger LP
J Microbiol Immunol Infect; 2016 Oct; 49(5):788-796. PubMed ID: 26066543
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae.
Cheung YF; Huang GY; Chen SB; Liu XQ; Xi L; Liang XC; Huang MR; Chen S; Huang LS; Liu XQ; Chan KW; Lau YL
Pediatrics; 2008 Sep; 122(3):e608-14. PubMed ID: 18710885
[TBL] [Abstract][Full Text] [Related]
7. BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children.
Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai FJ
Eur J Pediatr; 2010 Jun; 169(6):713-9. PubMed ID: 19882345
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y
J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520
[TBL] [Abstract][Full Text] [Related]
9. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
[TBL] [Abstract][Full Text] [Related]
10. Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Hong YM; Jin HS; Park IS; Hong SJ
Heart Vessels; 2008 Sep; 23(5):341-7. PubMed ID: 18810583
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I chain-related gene polymorphisms: associated with susceptibility to Kawasaki disease and coronary artery aneurysms.
Hsieh YY; Chang CC; Hsu CM; Chen SY; Lin WH; Tsai FJ
Genet Test Mol Biomarkers; 2011 Nov; 15(11):755-63. PubMed ID: 21815799
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor gene haplotypes in Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Ottenkamp J; Kuipers IM; Lam J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Arthritis Rheum; 2006 May; 54(5):1588-94. PubMed ID: 16645995
[TBL] [Abstract][Full Text] [Related]
13. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease.
Yamamura K; Ihara K; Ikeda K; Nagata H; Mizuno Y; Hara T
Int J Immunogenet; 2012 Apr; 39(2):119-25. PubMed ID: 22117627
[TBL] [Abstract][Full Text] [Related]
14. The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children.
Huang FY; Chang TY; Chen MR; Lee HC; Chiu NC; Chi H; Hsu CH; Lin SP; Liu HF; Chen WF; Chu CC; Lin M; Lee YJ
Hum Immunol; 2008 Jan; 69(1):52-7. PubMed ID: 18295676
[TBL] [Abstract][Full Text] [Related]
15. The
Wang Y; Lu Z; Fu L; Tan Y; Che D; Huang P; Pi L; Xu Y; Liang Q; Zhang L; Qiu X; Gu X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31043452
[TBL] [Abstract][Full Text] [Related]
16. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins.
Breunis WB; Davila S; Shimizu C; Oharaseki T; Takahashi K; van Houdt M; Khor CC; Wright VJ; Levin M; Burns JC; Burgner D; Hibberd ML; Kuijpers TW;
Arthritis Rheum; 2012 Jan; 64(1):306-15. PubMed ID: 21905000
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide Polymorphism rs17860041 A/C in the Promoter of the
Shi R; Luo Y; Li S; Kong M; Liu X; Yu M; Wu J; Huang L; Yang Z
Immunol Invest; 2021 Feb; 50(2-3):230-242. PubMed ID: 32079425
[No Abstract] [Full Text] [Related]
18. [Correlation between -31 T/C polymorphisms of
interleukin-1β gene and Kawasaki disease].
Zou D; Ahmed Mohamed E; Jiang J; Tian L; Chen J; Li Z; Yang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):8-12. PubMed ID: 28216491
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease.
Simonini G; Corinaldesi E; Massai C; Falcini F; Fanti F; De Martino M; Cimaz R
Clin Exp Rheumatol; 2009; 27(6):1026-30. PubMed ID: 20149326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
